The purpose of this study is to find out whether upfront emapalumab treatment can help in sAA (Aplastic Anemia) treatment planning and increase the effectivene…

Aplastic AnemiaCytopeniaHypocellular Marrow

~Estimated

~$10 – $6,250

Memorial Sloan Kettering Cancer CenterNCT06430788

Phase 2

A Study of T-Cell Replete, HLA-Mismatched Haploidentical Bone Marrow Transplantation With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia Lacking HLA-Matched Related Donor

Severe aplastic anemia is a rare and serious form of bone marrow failure related to an immune-mediated mechanism that results in severe pancytopenia and high r…

Severe Aplastic Anemia

~Estimated

~$10 – $6,250

Northside Hospital, Inc.NCT02828592

← PreviousPage 3 of 3Next →